WORK Medical (WOK) CFO Liang Ningfang submits initial Form 3

Rhea-AI Filing Summary

WORK Medical Technology Group LTD reported that Liang Ningfang, the company’s Chief Financial Officer, has filed an initial statement of beneficial ownership on Form 3. This filing establishes Liang’s status as an insider of WORK Medical but does not report any share transactions or holdings details in the provided data.

Key Terms

Chief Financial Officer, Form 3, reporting person

3 terms

Chief Financial Officer financial

"officer_title": "Chief Financial Officer""

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

""reportingPersons": ["

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liang Ningfang

(Last) (First) (Middle)

65 GRASSMAN PL L-3

(Street)

BERKELEY HEIGHTS NEW JERSEY 07922-2142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
WORK Medical Technology Group LTD [ WOK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Ningfang Liang	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the WORK Medical (WOK) Form 3 filing by Liang Ningfang show?

The Form 3 filing shows that Liang Ningfang is an insider of WORK Medical Technology Group LTD as Chief Financial Officer. It is an initial statement of beneficial ownership and, in the provided data, does not list any specific share transactions.

Who is the insider named in WORK Medical Technology Group LTD (WOK) Form 3?

The insider named is Liang Ningfang, who serves as Chief Financial Officer of WORK Medical Technology Group LTD. This role classifies Liang as a reporting person under SEC rules, requiring disclosure of beneficial ownership on Form 3 when insider status is established.

Does the WOK Form 3 filing report any share purchases or sales by Liang Ningfang?

No, the provided Form 3 data reports no share purchases, sales, or other transactions by Liang Ningfang. All transaction counts and share amounts, including buys, sells, exercises, and gifts, are shown as zero in the transaction summary for this filing.

What is the significance of a Form 3 for WORK Medical (WOK) investors?

Form 3 marks the point when an individual becomes a reporting insider at WORK Medical Technology Group LTD. It provides a regulatory starting point for future Form 4 and Form 5 updates, which will disclose any subsequent trading or changes in beneficial ownership by that insider.

Is Liang Ningfang a major shareholder of WORK Medical Technology Group LTD (WOK)?

Based on the provided data, Liang Ningfang is not listed as a ten percent owner of WORK Medical Technology Group LTD. The Form 3 flags Liang as an officer, specifically Chief Financial Officer, but not as holding at least ten percent of the company’s shares.